IRIB |
"SeNSO" SEnsore Nanostrutturato per Stress Ossidativo
| oxidative stress, electrochemical sensor, hydrogen peroxide | E. Pace |
IBBC |
"Shedding laser light" on the molecular and cellular functions of DDX11 and FANCJ DNA helicases
| DNA replication; Genome stability; Cell cycle; DNA helicases; Fork-protection complex | F. M. Pisani |
IBBC |
“Antarctized” antibody: an innovative monoclonal antibody engineered by the CRISPR/Cas9 system
| engineered monoclonal antibody; genome editing; Immunoglobulin gene locus | M.R. Coscia |
IGM |
3D Muscle-Tendon Unit modelling for unravelling tissue crosstalk in muscular dystrophies and aging
| --- | G. Lattanzi, E. Mattioli et al. |
ITB |
A bioinformatic landscape for ncRNA data analysis and functional characterization
| ncRNA, bioinformatics, gene regulation | F. Licciulli |
IGB |
A crossroad of epigenetic/omic control: insights into the KAP1/ZFP57 network of factors
| Epigenome; DNA methylation; KAP1/ZFP57 | G. Grimaldi |
IBPM |
A green technology to remove arsenic from soils and drinking water
| arsenic; phytoremediation; environment | P. Brunetti, M. Cardarelli |
IBBC |
A monoclonal antibody targeting connexin hemichannels as novel therapeutic approach for the treatment of Clouston syndrome
| Antibody drug discovery, Connexins, Genodermatosis, Epidermis, Sebocytes, Calcium, ATP | C. Peres, F. Mammano |
IBB |
A new platform for generating multispecific antibody formats and new antibody drug conjugates
| Multimeric antibody formats, Recombinant Fab, Trastuzumab, Cripto-1, ADC | M. Ruvo |
IBB |
A stapled AIF mimicking peptide targeting AIF/CypA lethal complex
| neurodegenerative and heart diseases, protein-protein interaction, drug development | N. Doti |
IBFM |
Abnormal metabolic states, aging, gender and neurodegenerative processes
| Aging, Metabolism, Neuroinflammation | S. Belloli |
IGM |
Abstract
| DNA repair, RNase H2, DNA Pol Lambda | E. Crespan |
IN |
AChE inhibitors as regulators of α7nAChR and its human-restricted duplicated isoform, CHRFAM7A, expression and modulation of the cholinergic antiinflammatory pathway in AD
| CHRNA7, CHRFAM7A, cholinergic anti-inflammatory pathway | R. Benfante |
IN |
ACTION OBSERVATION TREATMENT FOR MOTOR REHABILITATION
| Action observation, plasticity, motor abilities, neurorehabilitation, motor imagery | P. Avanzini |
IN |
ACTION PREDICTION
| action prediction, motor intention, action planning, action preparation, driving | G. Vecchiato |
IBB |
Advanced approach for ApoE−/−Fbn1C1039G+/−mouse characterization: a suitable model of vulnerable atherosclerotic plaque
| Atherosclerosis, High Frequency Ultrasound, mouse model | S. Albanese |
IBBC |
Advanced label-free microscopy for application in cell biology
| Raman microscopy, SERS, imaging, label-free, cancer | A.C. De Luca |
IBBC |
Advanced morphology: imaging and microscopy
| Euro-bioimaging infrastructure, Advanced morphology: imaging and microscopy, mammalian secretory pathway | M. Pirozzi |
IFT |
Aging and senescence: from DNA damage to muscle regeneration
| --- | L. Latella |
IN |
Altered forebrain GABAergic postanatal inhibitory interneurons in a mouse model of intellectual disability- autism spectrum disorder
| ID-ASD, inhibitory interneurons, postnatal neurogenesis, OPHN1 | C. Lodovichi |
IN |
Altered protein translation pathways in epilepsy
| Protein translation, Dravet syndrome, inhibitory synapses, genetic models of epilepsy | C. Sala |
IGM |
Alternative splicing regulation in angiogenesis and in tumor vasculature
| Alternative splicing, Angiogenesis, RNA Binding Proteins | C. Ghigna |
IGB |
Alu RNAs as novel therapeutic targets and biomarkers in colorectal cancer
| Alu RNAs, colorectal cancer, exosomes | V. Tarallo |
IN |
An Angiopep2-PAPTP construct overcomes the blood-brain-barrier. Perspectives against glioblastoma
| PAPTP, Angiopep-2, Brain delivery | L. Biasutto |
IBBC |
An integrated platform for specific and selective histone deacetylase inibitors (HDACiPLAT)
| Istone deacetylase inhibitors, Schistosoma mansoni, cancer, integrated drugdiscovery platform | G. Ruberti, F. Saccoccia |
IBIOM |
Analysis of microbial communities in agro-food, environmental, animal and human samples by metagenomic approaches
| Metagenomics, Microbiome, Extremophiles | L. Ceci |
IFT |
Analysis of the genetic and functional mechanisms underlying the inflammatory immunological response processes in the field of kidney transplants and in oncology: definition of biomarkers predicting immune dysregulation
| HLA, kidney transplantation, cancer, stem cell transplantation, KIR, CTLA-4 | A. Canossi |
IBBC |
Antioxidant action of plant polyphenols in the counteraction of alcohol-abuse induced damage: Impact on the Mediterranean diet
| AUD, NGF, BDNF, oxidative stress | M. Fiore |
IFT |
A-to-I RNA editing in cancer
| RNA editing, post-transcriptional modifications, glioblastoma therapy | V. Cesarini |
IBPM |
Automated high-content imaging to study the response of human cells to novel anti-cancer treatments and identify new therapeutic targets
| single-cell imaging; high-content microscopy; genotype/phenotype analysis | L. Asteriti, C. Rinaldo |
IBBC |
Autoregulatory circuit regulating basolateral cargo export from the TGN: role of the orphan receptor GPRC5A in PKD signaling and cell polarity
| Apico-basal polarity, autoregulatory systems, basolateral cargo, PKD signaling, TGN export | R. Di Martino |
IBPM |
Bacterial P450 cytochromes as tools for designing alternative pharmacological agents
| cytochromes P450; structural Biology; drug design and discovery | L. C. Montemiglio, C. Savino |
IBB |
BactiVax, a European Anti-Bacterial Innovative Vaccine Training Network
| Bacterial infections, respiratory disease, protein structure | R. Berisio |
IRIB |
Big data in Environmental and occupational EPidemiology (BEEP)
| Air pollution; Big Data; Hospitalization; Morbidity; Mortality; Noise; Temperature | S. La Grutta, G. Viegi |
IBBC |
Biochemical and molecular studies on enzymes involved in cell detoxification
| regulation of catalysis; structure-function relationships; detoxification | G. Manco |
IBPM |
Biocrystal Facility: a structural biology hub for Italian researchers and companies
| structural biology; X-ray crystallography; single particle cryo-electron microscopy | L. C. Montemiglio, A. Di Matteo |
ITB |
Bioinformatics @ ITB
| bioinformatics, computational biology, BigData integration | F. Licciulli, E. Mosca |
IGM |
Bioinformatics data analysis @IGM
| Bioinformatics, Data analysis, Cloud computing | R. Alfieri |
IBPM |
Bioinformatics@IBPM: from atomic level to genome-scale data analysis, and the ELIXIR-Italy Training Platform
| structural bioinformatics; computational genomics; ELIXIR training | T. Colombo, L. Le Pera |
ITB |
Biomedical image and signal processing
| medical imaging, biomedical signal processing, image-based biomarkers | G. Rizzo |
IN |
Biomolecular condensates in neuromuscular and neurodegenerative diseases
| TDP43, secretory phospholipases A2, phase transition | F. Tonello, M. L. Massimino |
IBB |
Biomolecular NMR spectroscopy
| NMR spectroscopy, biomolecular interactions; drug discovery | D. Diana, M. Leone |
IGM |
Bone Cancer Group, IGM-CNR, UOS Bologna
| Sarcoma, RNA metabolism, stress/inflammation | W. Blalock, M.Piazzi |
IN |
Boosting cholinergic signaling to rescue social deficits in an animal model of Autism
| social memory, CA2 region,, interneurons | M. Griguoli |
IN |
Cadherin dysfunctions hack brain wiring leading to neurodevelopmental disorders
| encephalopathy, epilepsy, autism | M. Passafaro |
IBPM |
Calcium dyshomeostasis as a marker of ER stress, chemotherapeutic drug resistance and neurodegeneration
| calcium homeostasis; cancer; neurodegeneration | G. Colotti, A. Ilari |
IGB |
Cancer Molecular Analysis by ‘OMIC’ and ‘Cancer Modeling’
| Patient-derived Tumor Organoids; Drug Resistance; Anti-cancer agents | E. Caputo |
IGB |
Cancer-specific ultraconserved long noncoding RNA 8 as a novel biomarker for early bladder cancer detection
| Bladder cancer; prognostic biomarker; ultraconserved region; Transcribed-ultraconserved region; long noncoding RNA; ultraconserved transcript 8+: uc.8+; | A. Cimmino |
IBBC |
Cardiac stromal cells biology and contribution to tissue repair and regeneration
| Cardiac repair, stromal cells, regeneration | F. Pagano |
IGB |
Cardiogenesis and congenital heart disease
| Congenital heart disease, Multipotent Cardiac Progenitor , Extracellular matrix | D. Alfano, G. Lania |
IN |
Cellular and Molecular Mechanisms in neurodevelopmental disorders and brain tumors
| FOXG1-related disorders; glioblastoma; cell signalling | M. Costa |
IN |
Cellular and molecular mechanisms of neuronal disease
| mitochondrial bioenergetics, intracellular calcium balance, neuronal metabolomics | L. Colombaioni |
IBFM |
Characterization of cancer evolution and intra-tumor heterogeneity from single-cell sequencing data
| Cancer evolution, Intra-tumor heterogeneity, Omics data integration, artificial intelligence, machine learning, single-cell sequencing, scRNA-seq data | A. Graudenzi |
IBBC |
Characterization of novel lncRNA associated to EMT intermediate phenotypes and resistance to target therapy in NSCLC (LEARN)
| long non coding RNA (lncRNA), non small cell lung cancer (NSCLC), target-therapy resistance, epithelial to mesenchimal transition (EMT) | G. Ruberti, V. Fustaino |
IRGB |
Characterization of the immune response in murine models of disease
| immunodeficiency, autoimmunity, innate and adaptive immunity, murine models | V. Marrella |
IN |
Characterization of the intracellular and mitochondrial Ca2+ signaling in physiology and pathology
| mitochondrial Ca2+; Ca2+ signaling; human pathology | G. Pallafacchina |
IRGB |
Chromosome Transplantation, a new approach to treat X-linked diseases
| Genetic Therapy; Chromosome Transplantation; X-linked Diseases; Lesch Nyhan Disease, X-linked Duchenne Muscular Dystrophy | M. Paulis |
IRGB |
Cigarette Smoke: Study of Immune system dysregulation in the ProgeNia cohort
| Cigarette smoke, Immune system, Transcriptome profiling | M. Marongiu, V. Serra, V. Orrù, M. Pala, M. Steri |
IBB |
Circulating extracellular vesicles with liver-specific RNA species and proteome are potential biomarkers for early liver fibrosis in experimental cholestasis
| fibrosis, extracellular vesicles, biomarkers | S. Fagoonee |
ITB |
Circulating miRNAs in small extracellular vesicles secreted by a human melanoma xenograft in mice brain
| extracellular vesicles; microRNAs; metastatic melanoma | I. D'Agnano |
IFT |
Classical and non-classical HLA polymorphisms in long-term monitoring of kidney transplantation and diseases
| HLA-G, transplantation, obesity | D. Piancatelli |
IRGB |
Clinical translational research using NGS technologies: DNA methylation, gene mutations and circulating microRNAs, from bench to clinic
| NGS, Diagnostic biomarkers, Liquid biopsy, microRNA, DNA methylation, Gene mutation | R. Roncarati |
IBBC |
CNR-IBBC Monterotondo mutant strain production: open doors for new mouse models
| genetically modified mouse models | F. Chiani, A. Gambadoro, M. Pasquini |
IRGB |
Cohesin: a new player in cancer development
| Cohesin, Cancer, Rare diseases | A. Musio |
IBFM |
Computational methods for biomedical data science
| biomedical data science, data integration, multi omics, AI, machine learning, cancer evolution, SARS-CoV-2, metabolic networks, precision medicine | A. Graudenzi |
IBBC |
Connexin hemichannel-mediated ATP release drives spontaneous Ca2+ signaling in the greater epithelial ridge of the developing cochlea
| whole cell-based biosensors, ATP release, connexin hemichannels, calcium signaling, developing cochlea, microfluidic chip | C. Nardin, F. Mammano |
IN |
CONSCIOUSNESS
| timing; neural correlate; tactile awareness; neglect; stroke | P. Avanzini |
IBBC |
Conserved motifs in the cytoplasmic tails of human Golgi-glycosyltransferases regulate enzyme dynamics
| Golgi, glycosyolation, cancer, trafficking, GOLPH3 | D. Russo, A. Luini |
IBBC |
Covid-19 and science communication: an opportunity to assess new formats in public engagement
| Covid19, science communication, digital transformation, public engagement | G. Catara |
IN |
Creatine Deficiency Syndrome: novel insight into brain function and therapeutic strategies
| creatine, intellectual disability, gene therapy | L. Baroncelli |
IBBC |
D2M – Digital Mouse Monitoring
| Artificial Intelligence, Mouse monitoring, Sensors, Home cage monitoring | M. Raspa |
IGM |
DAXX HISTONE CHAPERONE MODULATES DOUBLE STRAND BREAKS REPAIR PATHWAY CHOICE THROUGH H3.3 DEPOSITION
| DNA repair, Double strand breaks, Histone variant | G. Buscemi |
ITB |
Deciphering the role of DNA compartmentalization in human diseases
| Chromatin conformation, laminopathies, cancer | C. Lanzuolo |
IN |
Defining the mechanisms underpinning the mitochondrial cAMP signalling
| cAMP, mitochondria, signalling microdomains | G. Di Benedetto |
IFT |
Degenerative and genetic brain diseases: correcting synaptic and circuits dysfunctions to rescue cognition
| pre-sympthomatic Alzheimer Disease; memory; neural compensation; synaptic plasticity; network disfunciton; Autism Spectrum Disorder; Gender specificity; Chemogenetic Tools. | A. Pignataro |
IBBC |
Detection of sleep-related disturbances in mouse models of neurological diseases using a novel automated home cage monitoring system
| ALS, sleep, circadian rhythm, home cage monitoring4, neurodegeneration, neuromuscular diseases, mouse behavioral phenotyping | S. Mandillo |
IN |
DEVELOPING A BRAIN CLEARING TECHNIQUE TO STUDY FUNCTIONAL CONNECTIVITY
| brain clearing; functional connectivity; high-throughput analysis; quantitative image analysis | S. Morara |
IFT |
Development of innovative biotechnological and therapeutic strategies in Regenerative Medicine and Tissue Engineering
| Rigenerative Medicine, Tissue engineering, Nano-biotecnology | A. Lisi, M. Ledda |
IBB |
Development of integrin subtypes selective peptides for theranostic applications
| Integrins, selective peptide ligands, design, synthesis, chemical modification, theranostic, structure-activity relationship | L. Zaccaro, A. Del Gatto |
IBFM |
Development of multimodal phantom for molecular imaging
| Phantoms, Radiomics, 3D printing | F. Gallivanone |
IBBC |
Development of new bioreceptors to be used in biosensors and/or diagnostic kits for the monitoring of toxic substances in humans and in the environment
| Bioreceptors, Biosensors, Toxic molecules, CG-MALS, Fluorescence | F. Febbraio |
IBFM |
Development of new radioligands for PET/SPET imaging
| Radiopharmacology, PET/SPET imaging, Animal models | S. Todde, S. Belloli |
IFT |
DIAGNOSTIC SERVICES FOR THE BAMBINO GESU’ CHILDREN’S RESEARCH HOSPITAL IRCCS
| organ transplantation, HLA polymorphism, alloantibody | G. Ozzella |
IBPM |
Dissecting the interplay between integrin and endothelin signaling in invadopodia and metastatic process of ovarian cancer: new therapeutic approaches
| organoids; cancer cell invasion and metastasis; invadopodia | L. Rosanò |
IBPM |
Dissecting the role of GOLPH3 in cytokinesis
| cytokinesis; GOLPH3; myosin | S. Sechi, M. G. Giansanti |
IBPM |
Dissecting the role of lncRNAs in skeletal muscle differentiation and regeneration
| noncoding RNAs; muscle stem cells; muscle differentiation | J. Martone, C. Mozzetta |
IRGB |
Dissection of white blood cells regulatory genetic mechanisms using a co-expression network from RNA-seq transcriptomes of 624 individuals
| Gene co-expression network, WGCNA, white blood cells | P. Forabosco |
IBPM |
Drosophila models to study neurodegenerative and neurological disorders
| Drosophila; neurodegeneration; neurological disease | M. Di Salvio, G. Cestra |
IFT |
Dysfunction of RNA/RNA binding proteins in motor neuron diseases
| Amyotrophic Lateral Sclerosis, RNA metabolism, neurodegeneration | M. Cozzolino |
IN |
Early dysfunctions of intracellular Ca2+ signaling and bioenergetics in Alzheimer’s Disease
| calcium signaling, FAD (familial Alzheimer’s disease), mitochondria | E. Basso, R. Filadi |
IBBC |
Effect of cigarette smoke on vascular integrity: the role of circulating miRNAs
| miRNA, circulating miRNA, endothelial function | F. Pagano |
ESFRI-ELIXIR |
ELIXIR-IT: the Italian Node of the European Research Infrastructure for Life Science
| Research Infrastructure, Bioinformatics, Integrative Omics | G. Pesole |
IRGB |
Elucidate the CRLF1 immunoregulatory role through Integrated immunophenotyping, proteomic and transcriptional profiling in CS/CISS1 cases
| CRLF1, immune cell function, hematopoiesis, Crisponi/Cold- induced sweating syndrome type 1 (CS/CISS1), CLCF1 | L. Crisponi |
IFT |
Endocannabinoid System in Human Disorders
| endocannabinoid system; endocannabinoids, bioactive lipids | T. Bisogno |
IN |
Entorhinal cortex as a model to study synaptic function and neurodegeneration
| Alzheimer’s disease, inflammation, hippocampus | N. Origlia |
IN |
Epidemiology of aging and biostatistics
| epidemiology; aging; healthy aging | F. Limongi, M. Noale |
IRGB |
Epigenetic and Transcriptional Programs controlling cardiomyocyte proliferation and cardiac fibrosis
| Cardiomyocyte proliferation, Fibrosis, Epigenetics | P.L. Cattaneo |
IGB |
Epigenetic control of cellular identity in human primary immunodeficiencies
| Epigenetic syndromes, DNA/Histone methylation, patient-derived iPSCs | M.R. Matarazzo |
IBBC |
Epigenetics of alcohol consumption and abuse during gestation
| Epigenetic, Alcohol Use Disorders, Fetal Alcohol Spectrum Disorders | M. Fiore |
IRGB |
Erythropoiesis stage specific transcriptional signatures in primary erythroid cells in healthy and β-thalassemia patients
| Erythropoiesis; RNAseq; Novel genes | M. Uda, M. Pala |
IRGB |
ERYTHROPOIESIS, HEMOGLOBIN EXPRESSION AND SWITHCING. THE HUMAN δ-GLOBIN GENE AS A THERAPEUTIC TOOL FOR β- HEMOGLOBINOPATHIES. POST GWAS TARGET VALIDATION AND EVALUATION OF MOLECULES IN PRECLINICAL MODELS.
| β-hemoglobinopathies, δ-globin, preclinical mice models | M.S. Ristaldi |
ESFRI-EUBI |
Euro-BioImaging ERIC – The European Research Infrastructure for Advanced light microscopy (ALM) imaging: general overview and presentation of the Italian ALM Node
| Biological imaging, cellular imaging, research infrastructure, ESFRI | S. Parashuraman, E. Greotti |
ESFRI-EUBI |
Euro-BioImaging ERIC – The European Research Infrastructure for Biological and Medical Imaging: general overview and presentation of the biomedical imaging Italian Nodes
| Biomedical imaging, research infrastructure, user access | S. Aime, A. Viale, E. Terreno |
IFC |
EUROlinkCAT - Long term outcomes in children with congenital anomalies
| congenital anomaly, linkage, mortality | A. Pierini |
ITB |
Exogenous Plant miRNAs have a cross-Kingdom regulatory roles in the human metabolism
| exogenous plant miRNAs, ncRNA, cancer | D. Catalano |
IBBC |
Experimental approaches to investigate the Nerve Growth Factor receptor-mediated actions
| biological activity; cleavage; NGF processing; small peptides | P. Tirassa |
IGM |
EXPLORING THE INVOLVEMENT OF COLVI-NG2 AXIS IN THE GENERATION OF CONTRACTURES AFFECTING UCMD PATIENTS
| Collagen type VI-related myopathies, Mechanosignaling, Extra Cellular Matrix | S. Squarzoni, P. Sabatelli |
IGM |
Exploring the molecular mechanisms regulating vector capacity in the tiger mosquito, Aedes albopictus
| arboviruses, RNA helicases, viral replication | F. Scolari |
ITB |
Exploring transcriptional single-cell signatures in an embryonic mouse model of epilepsy
| single-cell RNASeq; embryonic mouse brain; epilepsy | E. Mangano, C. Consolandi |
IGB |
Extracellular and intracellular control of pluripotency: beyond transcription factors
| pluripotency; neural differentiation; non-coding RNAs | A. Fico, G. Minchiotti |
IRIB |
Extracellular vesicles from a natural source
| Extracellular Vesicles (EVs), bio-nanotechnology, drug delivery system, renewable bioresource | A. Bongiovanni |
IN |
Extracellular Vesicles mediators of anti-inflammatory and neuroprotective action and potential novel biomarkers for Alzheimer’s Disease
| Extracellular Vesicles; therapeutical strategy; biomarkers; Alzheimer’s Disease; Mesenchymal Stem Cells | M. L. Malosio |
IGB |
Extrinsic regulation of muscle stem cells and inflammatory cells in skeletal muscle regeneration and muscular disease
| Skeletal muscle regeneration; regenerative medicine; Cripto | G. Minchiotti, O. Guardiola |
IFT |
From human health findings to the pre-clinical development of new therapeutic strategies
| 3D-Bioprinting, Neuroinflammation, Parkinson, cannabinoids, opioids, antipsychotics | M.A. Casu |
IGB |
Functional analysis of hemoglobinophaty mutants and regulation of expression of human lactonase PON2
| Hemoglobinotaphies; transciptional analysis; regulation of expression of the PON2 gene | G. Lacerra |
IN |
Functional effects and molecular mechanisms of the transcytosis of pathogenic molecules
| neurotoxins, axonal trafficking, synaptic vesicles | L. Restani |
IRGB |
Functional impairment of osteoblasts derived from Shwachman-Diamond syndrome patients: new pharmacological approaches to overcome the genetic mutation
| Shwachman-Diamond Syndrome, osteoblast, PTC read-through | A. Frattini |
IBBC |
G protein-coupled receptors’ signaling, cerebellum development and medulloblastoma occurrence
| Cerebellum; Proliferation; GPCRs | D. Marazziti, G. La Sala, C. Di Pietro |
IBB |
Galectins: Structure, function and therapeutic potential inhibitors
| galectin-fold; galectin-inhibitor; anti-tumoral agents; Spike protein | E. Pedone |
IN |
Gene therapy and CRISPR/Cas9 epigenomic editing for treating neurodevelopmental disorders
| gene therapy, AAV, CRISPR/Cas9, genome editing, neurodevelopmental disorders | V. Broccoli |
IGB |
Genetic and epigenetic mechanisms deregulated in Rett syndrome
| Rett syndrome; MeCP2; Glycosphingolipids | F. Della Ragione |
IRGB |
Genetic and molecular alterations in pancreatic cancer by next-generation sequencing
| Pancreatic cancer, NGS, targeted therapy | L. Frogheri, M.G. Doro, M.C. Sini |
IGB |
Genetic and Pharmacological rescue strategies in a neurovascular congenital disease
| Brain neurovascular development, genetic and pharmacological rescue, mouse models | S. Cioffi, G. Flore |
IBFM |
Genetic Biomarkers in Epilepsy
| Epilepsy, Imaging biomarkers | A. Gambardella |
IFT |
Genetic factors predictive of risk of cancer and neurological disease
| HLA, CD16, CD1 | A. Aureli |
IRGB |
Genetic regulation of immune traits, implication on diseases and their therapies
| Immune traits, GWAS, autoimmunity | V. Orrù, M. Steri, C. Sidore, E. Fiorillo, F. Cucca |
IGB |
Genetics of common trait and rare diseases in population isolates: the Cilento study
| genetic epidemiology, omics data, rare disease | M. Ciullo, D. Ruggiero, T. Nutile |
IN |
GENETICS OF FAMILIAL TEMPORAL LOBE EPILEPSIES
| ADLTE, FMTLE, whole exome sequencing, causal genes, mechanisms of mutations | C. Nobile, E. Dazzo |
IGM |
Genome integrity and cell cycle checkpoints
| DNA damage response; DNA repair; p21-PCNA interaction | E. Prosperi |
IGM |
Genome-wide characterization of the genomic and splicing features of long non-coding RNAs using bioinformatics approaches
| Long non-coding RNAs, Bioinformatics, Splicing mechanisms | S. Bione |
IRGB |
Germline and somatic NGS-based analysis on BRCA-related tumors
| BRCA1-2 genes, NGS, PARP-AR inhibitors | M.C. Sini, G. Palomba, M. Pisano |
IN |
GLIAL MICROVESICLES IN MOTION AT THE NEURON SURFACE: IMPLICATION IN ALZHEIMER’S DISEASE
| extracellular vesicles, synaptic dysfunction, PrP, extracellular motion, Alzheimer’s disease | C. Verderio |
IBBC |
Golgi complex disassembly duringG2/M transition: An organelle-based cell-cycle checkpoint
| Golgi complex, cell cycle, combinatorial treatment, cancer | A. Colanzi |
IBBC |
Golgi enzyme organization controls fidelity in glycan biosynthesis
| Glycosylation, Golgi, cell growth, glycosphingolipids | S. Parashuraman |
IRGB |
GUT MICROBIOTA FUNCTIONAL DYSBIOSIS AND IMPACT OF INDIVIDUAL DIET IN SUBCLINICAL CAROTID ATHEROSCLEROSIS
| Atherosclerotic Cardiovascular Diseases; Gut Microbiota; next generation sequencing | M. Severgnini, C. Peano |
IBPM |
HD-Zip II transcription factors in auxin-regulated plant development
| Arabidopsis; transcription factors; plant development | G. Sessa, M. Carabelli |
IFT |
Highly specialized services in the field of histocompatibility and assessment of donor / recipient alloreactivity in organ transplantation
| organ transplantation, HLA antibodies, AT1R antibodies, C1q antibodies | E. Poggi |
IGB |
HLA-DQ2.5 genes: role in immuno-modulation mechanisms of Celiac Disease
| autoimmunity, HLA, expression | G. Del Pozzo, L. Pisapia |
IBB |
Host-pathogen interactions in viral diseases: the case of SARS-CoV-2
| protein-protein interactions, respiratory disease; protein structure | R. Berisio |
ITB |
Human brain neuromelanin: from biochemistry to its potential application as biomarker of neurodegeneration
| neuromelanin, aging, neurodegeneration | F. A. Zucca |
IN |
HUMAN EMOTIONS
| emotion recognition, emotional behavior, social cognition, mirror mechanism | F. Caruana |
IBPM |
Hydrogen sulfide, a signaling molecule across life kingdoms
| drug targets, signalling, bacterial physiology | A. Giuffré |
IBBC |
Identification and treatment of early cognitive deficits during ageing to prevent dementia
| ageing, dementia, Alzheimer disease, autophagy, sex differences | E. De Leonibus |
IBBC |
Identification and treatment of neural mechanisms underlying early behavioral symptoms in Parkinson's disease
| Memoria motoria, plasticità sinpatica, malattia di Parkinson, retina, alfasinucleina | E. De Leonibus |
IGB |
Identification of druggable molecular pathways underlying neurodevelopmental disorders
| Single-cell RNA sequencing; Neuro-inflammation and microglia; Anti-seizure drugs | M.G. Miano |
IBPM |
Identification of inhibitors of the unique trypanothione metabolism to fight parasitic neglected diseases
| neglected diseases; structural biology; structure based drug discovery | G. Colotti, A. Ilari |
IBBC |
Identification of miRNA and /or circRNA involved with Parkinson Disease
| progranulin, parkinsonism, genetics, dementia, gaze palsy, CRISPR-Cas9, Induce Pluripotent Stem Cells (iPSCs) | E. Vitale |
IBFM |
Identification of molecular imaging markers in PD mouse models
| PD mouse models, Early disease markers, PET-CT imaging | S. Belloli |
IBFM |
Identification of radio-epigenomic signatures in oncology
| Radiomics, Epigenomics biomarkers, Bioinformatics | F. Gallivanone |
IN |
Identification of recovery-associated prognostic biomarkers and novel cellbased therapeutic strategies
| stroke, biomarkers, cell-based therapy | C. Alia |
IRGB |
Idiopathic pulmonary fibrosis (IPF) and lung cancer
| Idiopathic Pulmonary Fibrosis, Lung Cancer, NGS | I. Persico, M.C. Sini, S. Casula |
IBFM |
Imaging Biomarkers in Parkinsonism
| Parkinsonism, Imaging, Biomarkers | A. Quattrone |
IBFM |
Imaging microvascular dysfunction
| Blood Flow, Coronary circulation physiopathology, Magnetic resonance, Positron emission tomography | O. Rimoldi |
IBFM |
Imaging of neuroinflammation in different neurodegenerative disorders
| Neuroinflammation models, Anti-inflammatory therapy, PET-CT imaging | S. Belloli |
CIN |
Immune challenge within the European Green Deal: profiling the impact of food-borne micro- and nanoplastics on human immune system
| immunotoxicology, microplastics, predictive models | P. Italiani, on behalf of the IBBC-CNR Immunology Group NAPOLI |
IBPM |
Immune regulation and immuno-monitoring in human diseases: auto-immunity, cancer, and COVID-19
| immuno-monitoring; immuno-therapy; cellular senescence | F. Di Rosa, F. Antonangeli |
IEOS |
Immunological Self-tolerance and Metabolism
| immunological self-tolerance, metabolism, Treg cells | G. Matarese |
IFT |
Impact of mutant p53 on miRNA biogenesis in colon cancer
| miRNA, colon cancer, mutant p53 | A. Gurtner |
IGM |
Improving the quality of life in progeria: a first trial in the murine Lmna G609G/G609G model using tocilizumab and different drug combinations
| --- | E. Schena, G. Lattanzi et al. |
IBFM |
In silico discovery of candidate drugs against COVID-19
| Bioinformatics, COVID-19, Drugs | C. Cava |
IBFM |
In silico drug discovery for cancer therapy
| Bioinformatics, Cancer, Gene network | C. Cava |
IBB |
In vitro diagnostic turbidimetric methods for SARS-CoV-2
| Sars-CoV-2; Diagnostic test; Turbidimetry | V. Menchise |
IN |
In vivo imaging of cortical plasticity in mouse models of stroke
| fluorescence imaging in vivo, mouse model of stroke, rehabilitation | A.L.A. Mascaro |
IN |
Increased response to 3,4 methylenedioxymethamphetamine (MDMA) reward and altered gene expression in zebrafish during short- and long-term nicotine withdrawal
| Psychostimulants, Conditioned Place Preference, reward, receptors | M. Sala |
IBBC |
Induction of Innate Immune Memory by Engineered Nanoparticles
| innate memory, nanoparticles, monocytes/macrophages | P. Italiani |
IRGB |
Induction of therapeutic levels of HbF in genome edited primary β°39-thalassemia HSPCs
| β-thalassemia, Fetal hemoglobin induction, CRISPR/Cas9 | M. G. Marini |
IEOS |
Inflammation, immunity and cancer
| inflammation, DNA damage, cancer immunotherapy | R.M. Melillo, A, Celetti, N. Prevete |
IBBC |
Innovative neuroimaging techniques applied to animal models to assess Neuroinflammation in Alzheimer’s Disease
| Small animal SPECT, Super Spatial Resolution, Neuroimaging application | R. Massari |
IBPM |
Innovative therapeutic strategy for Duchenne Muscular Dystrophy by AAV mediated delivery of artificial transcription factor genes
| Duchenne Muscular Dystrophy; artificial zinc finger transcription factor; gene therapy | IBPM - IBBC |
IGB |
Insights in Glioblastoma and Neural Stem Cell biology
| glioblastoma, neural stem cells, quality management tools | G.L. Liguori |
ITB |
Integrated approach based on transcriptomic and proteomic platforms to identify the biological mechanisms underlying the ALS disease
| transcriptomics, proteomics, ALS | R. Bordoni, P. Mauri |
ITB |
Integrated Multidisciplinary Approaches to uncover Molecular Mechanisms underlying Complex and Rare Neurological Diseases and their Phenotypes
| Neurological Rare Diseases, Transcriptomics, Biomarkers | M. Liguori, N. Nuzziello |
ITB |
Integrating pharmacogenomic and pharmacometabolomic data towards personalized opioid therapies for cancer pain
| SNP, GWAS, drug response | F. Colombo |
ITB |
Integration of exosome mirnome/proteome signature for identification of specific glioblastoma biomarkers
| extracellular vesicles; microRNAs; glioblastoma | I. D'Agnano |
IBBC |
Interaction Between Neurogenic Stimuli and the Gene Network Controlling the Activation of Stem Cells of the Adult Neurogenic Niches, in Physiological and Pathological Conditions
| neural stem cells activation, in vivo, neurogenic niches, hippocampus, memory, aging, neurodegenerative diseases | F. Tirone, L. Micheli |
IBBC |
Intestinal T-cell based assays: from basic science to translational application for treatment of celiac disease
| mucosal immunology; celiac disease, T cells, bioassays | C. Gianfrani |
IRGB |
Intracellular trafficking in kidney development and pathophysiology
| Endocytosis, Autophagy, Development, hESc, Organoids, Disease modeling | L. Staiano |
IN |
Investigating a new molecular mechanism acting upstream of the formation of neurotoxic Aβ1-42 species: novel therapeutic strategies for Alzheimer’s disease
| RNA binding proteins; drug design; RNA metabolism | A. Borreca |
IRGB |
Investigating molecular and cellular pathophysiological mechanisms of the bone tissue
| bone, osteoclast, osteoblast, genetics, murine models | C. Sobacchi |
IRGB |
Investigating the role of host-microbiota interaction in the pathogenesis of immunemediated disorders
| immunity, immunodeficiency, immune-mediated disease, microbiota, infection | B. Cassani c/o Humanitas Clinical and Research Center |
IBB |
Investigating tumor pH imaging as a novel cancer biomarker
| imaging, therapy, tumor metabolism | D. Longo |
IRGB |
IPSC-based models for investigating mechanisms primary cardiomyopathies: focus on LMNA gene and its pathophysiological role in the human cardiomyocyte
| Induced Pluripotent Stem Cells (iPSCs); Cardiomyopathy; Lamin A/C | E. Di Pasquale c/o Humanitas Clinical and Research Center |
IBPM |
Leukocyte telomere length as possible biomarker to track Huntington’s disease progression
| Huntington’s Disease; biomarker; Leukocyte Telomere Length | D. Scarabino, E. Mantuano |
IGM |
Leveraging 3D chromatin architecture for the study of non-coding regulatory regions variants
| Computational genomics; Epigenetics; 3D chromatin architecture | F. Ferrari |
ITB |
Linked-read sequencing for the discovery of structural variants in autism spectrum disorders
| autism; linked-read sequencing, structural variants | A. Mezzelani |
IRGB |
Liquid biopsy in clinical oncology
| liquid biopsy, circulating tumor DNA (ctDNA), anti-EGFR therapy | M. Casula, M. Pisano |
IN |
Longitudinal Health and Cross-Country Statistical Modelling
| Harmonization, Cross-country comparability; Longitudinal studies | N. Minicuci |
IBB |
Machine Learning for Clinical Radiobiology
| Radiotherapy, toxicity analysis, personalized medicine | G. Palma |
IN |
Mapping and molecular fingerprinting of synaptic memory engrams
| Alzheimer’s disease, associative learning and memory, dendritic spines | M. Mainardi |
IFC |
Maternal obesity and cognitive dysfunction in the offspring: cause-effect role of the GUT MicrobiOMe and early dietary prevention (GUTMOM)
| maternal obesity, microbiome, cognitive function | P. Iozzo |
IN |
Mathematical modelling
| diabetes, cardiovascular diseases, mathematical modelling | R. Bizzotto |
IRGB |
Mechanisms of cardiac disease and reverse cardiac remodeling during unloading
| Heart failure, cardiomyopathy, mouse models, non-coding RNA | M.L. Bang |
IGM |
Mechanisms that modulate replication fork stability and R-loop accumulation during the conflict with transcription
| DNA Damage; Replication-Transcription Collisions; R-loops | G. Liberi |
IBFM |
Mechanisms underlying the predictive power of high skeletal muscle uptake of FDG in amyotrophic lateral sclerosis
| Amyotrophic lateral sclerosis; Endoplasmic reticulum; Oxidative stress; SOD1G93A mouse model; Skeletal muscle; [18F]-Fluorodeoxyglucose. | C. Marini |
IBBC |
Medulloblastoma, tumor of the cerebellum: novel in vivo models and preclinical therapies
| cerebellar precursor cells, cerebellum development, medulloblastoma, gene therapy | F. Tirone, M. Ceccarelli, L. Micheli |
IGB |
Metabolic control of cell plasticity in physiology and disease
| cell plasticity, cell metabolism, drug-screening | C. D'Aniello, E.J. Patriarca |
IN |
Metabolic interventions to heal FoxG1-related Rett syndrome
| intellectual disability, autism spectrum disorders, epilepsy | M. Mainardi |
IGM |
Metabolic reprogramming and cancer progression
| metabolic reprogramming, metabolomics, cancer progression | G. Zadra |
IBFM |
Metabolomics Facility-ISBE Joint Research Unit
| Health, Metabolomics, Systems Biology | D. Gaglio |
IBIOM |
Metastatic spread and cancer chemoresistance: genetic and epigenetic mechanisms
| Epigenetics, cell signaling, metastasis | L. Moro |
IBBC |
microRNAs and LncRNAs in brain ageing and Alzheimer Disease
| miR-101, LncRNAs, Neurons, Hippocampus, Ageing, Alzheimer’s Disease | C. Barbato, F. Ruberti |
IBFM |
microRNAs as theranostics molecules in cancer
| microRNAs, Bioinformatics, Theranostics | C. Cava, G. Bertoli |
IN |
Microtomography of cerebral microcirculation in murine models of chronic pain
| X-ray nanotomography, chronic pain, neurovascular coupling | A. Zippo |
IBIOM |
Mitochondria: Hubs for signal pathways, cellular energetics and redox balance
| Mitochondria; signal transduction; oxidative stress | L. De Rasmo |
IBIOM |
Mitochondrial carriers: metabolic roles and pathologies
| mitochondrial carrier characterization, mitochondrial disease, drug-screening | E. Paradies |
IFC |
MMM – Medical Mockup Modelling
| mockup, 3D, cardiac imaging | C. Torino |
IFT |
Modulation of adult neurogenesis as a potential therapeutic tool for Alzheimer’s disease
| adult neurogenesis; Alzheimer’s disease; Ab-oligomers; intracellular targeting; intrabody; contextual fear conditioning | R. Scardigli |
ITB |
MOLECULAR AND CELLULAR BIOLOGY FINDINGS
| Precision and regenerative medicine; biomarkers (coding, non-coding and chromatin-complexes); high-throughput transcriptomics and super resolution microscopy | F. Adorni, Igea D'Agnano |
IN |
Molecular and cellular mechanisms underlying the relationship between metabolic alterations and cognitive decline
| dietary interventions, cognitive decline, metabolism | M. L. Malosio |
IGB |
Molecular and functional effects of methylglyoxal on human microvascular retinal cells
| diabetic retinopathy; retinal endothelium; transcriptional network | A. Ciccodicola, M. Aprile |
IBB |
Molecular dynamics simulation approach to study UV-induced DNA damage
| Molecular Dynamics simulations, DNA oxidative damage, G-quadruplex | L. Esposito |
IGB |
Molecular mechanisms governing angiogenesis in health and disease
| Angiogenesis, VEGF family, pathological neovascularization related diseases | S. De Falco |
IGB |
Molecular mechanisms of bone diseases and tumors
| bone diseases; skeletal sarcomas; Paget’s disease of bone; ZNF687; PFN1 | F. Gianfrancesco |
IBBC |
Molecular mechanisms of membrane fission at the Golgi complex
| Membrane traffic, Membrane Fission, Cellular Imaging | D. Corda, C. Valente, A. Luini |
IN |
Molecular mechanisms of synaptic dysfunction in UBE3A-linked neurodevelopmental disorders
| synaptic development, excitatory/inhibitory balance, CRISPR/Cas9, in utero electroporation, super-resolution microscopy, proteomics | M. Fossati |
IRGB |
Molecular mechanisms underlying cardiac muscle contraction and novel therapeutic approaches
| heart, cardiac disease, ion channel, calcium homeostasis, therapeutic approach, bioactive molecule, drug delivery, nanoparticles | D. Catalucci |
IBBC |
MOLECULAR STUDY OF GLUT1 DEFICIENCY SYNDROME: FUNCTIONAL CHARACTERIZATION OF CAUSATIVE MUTATIONS AND NEW GENOTYPEPHENOTYPE CORRELATIONS
| GLUT1, non-coding RNA | C. Parisi |
IN |
Monoamine oxidase A dependent ROS formation activates Akt/GSK3β signaling pathway to drive human cardiac differentiation
| reactive oxygen species, hiPSCs, cardiomyocytes | N. Kaludercic |
IBPM |
Moonlighting proteins in mitosis: new roles for splicing and nucleolar proteins
| mitosis; moonlighting proteins; splicing factors | C. Pellacani, P. Somma |
IN |
MOTOR LEARNING
| motor and cognitive development, action observation training, sport skills | M. Fabbri Destro |
ITB |
Multi-omics data and biological networks analysis for precision medicine
| Multi-omics, interactome, data integration | E. Mosca |
IRGB |
MUTATION PROFILES IN MELANOMA INITIATION AND PROGRESSION
| MAPK pathway, NGS, melanomagenesis | M. Colombino, A. Manca |
IRGB |
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer
| Colorectal cancer, RAS-BRAF genes, microsatellite instability | G. Palomba, M. Colombino, G. Maestrale |
IN |
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction
| ANKRD1, cardiac development; diastolic dysfunction; hemodynamics | M. Campione |
IGB |
Myofibroblastic activation in breast tumor microenvironment and inhibition of cancer-associated fibroblasts pro-invasive activity by novel peptides
| metastatic dissemination; αv Integrin; breast cancer-associated fibroblasts | M.P. Stoppelli |
IBFM |
Nanocarriers and targeting agents for imaging and treatment (theranostics)
| Nanocarriers, PET/SPET imaging, Theranostics | S. Todde, S. Belloli |
IBFM |
Nature-Inspired Biomedical Image Analysis for Precision Medicine
| Nature-inspired computing, Artificial intelligence, Medical image analysis, Biomedical data integration | C. Militello |
IN |
Network alterations in vivo in mouse models of autism and epilepsy
| autism, epilepsy, changes in network excitability | S. Landi |
IN |
NEUROAESTHETICS
| artworks, architecture, arousal, valence, approach-avoidance, body representations | G. Vecchiato |
IN |
NEUROBIOLOGY OF LANGUAGE
| language production, language comprehension, embodied cognition, motor theory of speech perception | F. Caruana |
IBBC |
Neurobiology of memory capacity
| memory capacity, neuronal circuits, AMPA receptors, dopamine, sex differences, cortical-subcortical plasticity, optogenetics | E. De Leonibus |
IBBC |
Neuroinflammatory Markers in the Serum of Children with Down Syndrome, DiGeorge Syndrome, and Klinefelter Syndrome
| NGF, BDNF, TNF-α, TGF-β, MCP-1, IL-1α, IL-2, IL-6, IL-10, IL-12, oxidative stress, genetic rare diseases | M. Fiore |
IN |
Neuromodulation and rehabilitation after stroke and brain damage
| neuromodulation, rehabilitation, robotics | C. Spalletti |
IBFM |
Neuroncology, treatment assessment with molecular imaging and biology
| Glioblastoma multiforme, Therapy, Molecular imaging and omics sciences | S. Valtorta |
IFT |
Neuroni chimicamente indotti come modello per lo studio dei meccanismi patogenetici e lo sviluppo di nuove strategie diagnostiche molecolari nelle malattie degenerative
| Malattie neurodegenerative, Transdifferenziamento, Conformeri proteici | C. Mollinari |
IFT |
Neuropharmacology of NGF and proNGF
| Nerve Growth Factor, Traumatic Brain Injury, Clinical Trials | L. Manni, M. Soligo |
IBBC |
Neuroprotective and inflammatory factors in neurodegenerative diseases: potential biomarkers
| Alzheimer’s and Parkinson’s diseases, chemokines, biomarkers, blood, cerebrospinal fluid | C. Severini, IBBC Unit at Department of Sense Organs, Sapienza University of Rome |
IBFM |
Neuropsychiatric features in Dementia & Neurodegeration
| Dementia, Neurodegeneration, Functional MRI, Structural MRI, Neuropsychiatry, Neuropsychology, Computational neuroscience, Psychopharmacology, Biomarkers | L. Passamonti |
IFT |
Neurotropic Viruses and Neurodegenerative diseases
| Neurotropic viruses, neurodegenerative disease, antivirals | G. De Chiara |
IEOS |
New biomarkers and therapeutic targets of human cancer
| aptamers, HMGA, lncRNA | L. Cerchia, M. Fedele, S. Zannini |
IGM |
Non-coding RNA components of the DNA damage response in neurodegeneration and diseases
| Genome Stability; non coding RNA; neurodegeneration | F. d’Adda di Fagagna, S. Francia |
IN |
Novel interdisciplinary approaches to molecular pathogenesis of Congenital Central Hypoventilation Syndrome: from basic to drug discovery
| PHOX2B, poly-alanine expansion disorders, IPS | R. Benfante |
IFC |
Novel precision technological platforms to promote non-invasive early diagnosis, eradication and prevention of cancer relapse: proof of concept in the bladder carcinoma (EDIT)
| nanomedicine, bladder cancer, gold nanorods, photoacoustic imaging, hyperthermia | L. Menichetti, F. Faita |
IGM |
Nucleotide excision repair (NER)-defective disorders as model system for carcinogenesis, neurodegeneration and ageing
| NER disorders, transcription regulation, cell cycle control | E. Botta, F.A. Peverali, D. Orioli |
IBBC |
Nutrition, metabolic disorders, aging, gender-differences, maternal and post-natal environment in incidence of neuropathy and pain: revealing new and selective pharmacological targets for a personalized medicine
| autophagy, myelin, glia, disease-related biomarkers, immune cells | S. Marinelli, V. Vacca, S. Luvisetto, F.R. D’Amato, F. Pavone |
IGB |
OTX2 controls epiblast contribution to germline and soma
| Otx2, pluripotency, primordial germ cells | A. Simeone, D. Acampora, L.G. Di Giovannantonio |
IFT |
p63 network in epithelial tumors
| squamous carcinogenesis, p53 family, transcription regulation, cancer cell stemness, Extracellular matrix-mediated signaling, lncRNAs | A. Peschiaroli |
IFT |
PASSIVE IMMUNIZATION WITH ANTIBODY TARGETING N-TERMINAL TRUNCATED TAU REVERSES NEUROPATHOLOGY AND COGNITIVE DEFICITS IN TWO PRECLINICAL MOUSE MODELS OF AD
| Tau cleavage, immunotherapy, Alzheimer’s Disease (AD) | G. Amadoro |
IBBC |
Pathogenetic mechanisms and therapeutic approaches for myotonic dystrophy
| myotonic dystrophy, circular RNAs, pathogenetic mechanisms, gene therapy | G. Falcone |
IRGB |
Pathophysiology and cure of immune bone inherited defects
| Immunodeficiency, Osteopetrosis, Gene Therapy | M.C. Castiello, V. Capo, A. Villa |
IFT |
Pathophysiology of reactive astroglia and microglia
| Glia, Microglia, Neurodegenerative diseases | L. Marlier |
IRGB |
Pbx1-directed stem cell transcriptional program drives tumor progression in myeloproliferative neoplasm
| Myeloproliferative neoplasm, JAK2V617F, Hematopoietic stem cells, Pbx1 | F. Ficara c/o Humanitas Clinical and Research Center |
IBBC |
Perspectives For Future Innovation in Tendon repair (P4 FIT)-H2020-MSCA-ITN-EJD- 955685
| tendon regenerative medicine; nanomedicines; stem cells; bioactive molecules, immunomodulation; artificial intelligence; biosensors; bioimaging, preclinical studies | B. Barboni |
IBBC |
Pharmacological targeting CtBP1/BARS-controlled endocytic pathway to block SARS-CoV2 infection
| COVID-19, Membrane trafficking, Cellular Imaging | C. Valente |
IFT |
Phospho-TCTP and Dihydroartemisinin: a Novel Therapeutic Opportunity in Advance Breast Cancer
| prognostic factor, combination therapy | M. Lucibello |
IRGB |
Pilot study of neonatal genetic screening in the Ogliastra population (Neogenia)
| screening, variants, genotyping | F. Cucca |
IRGB |
Post GWAS analysis of a BCL11A intronic region to define its role in regulating HbF levels
| Thalassemia; Fetal Hemoglobin; GWAS | M. Uda, C. Caria, F. Crobu |
IRGB |
Precision medicine in colorectal cancer: new clinical-genomic network for expanding tailored oncologic care
| Colorectal Cancer (CRC), Transcriptome, Single Cells (SC) | A. Angius |
IGB |
Precision medicine in Parkinson's disease: an integrated multidisciplinary approach to develop innovative protocols for early diagnosis and disease progression
| Diagnostic/prediction protocols for Parkinson’s Disease (PD); humanized mouse models for PD; Circulating biomarkers | T. Esposito |
IN |
Prenatal inflammation and altered neurodevelopment: the role of MeCP2
| synapse dysfunction, synaptogenesis, cytokines, maternal inflammation, neurodevelopment | I. Corradini |
IGB |
Prioritization of causative genomic variants in miscarried embryos from idiopathic pregnancy losses
| miscarriages, variant prioritization, whole-genome DNA sequence | V. Colonna, S. Buonaiuto |
IBBC |
Promising therapeutic applications of botulinum neurotoxins: nerve regeneration and functional recovery in a spinal cord injury mouse model
| botulinum, spinal cord, regeneration, neuroprotection, anti-inflammatory action | S. Luvisetto, V. Vacca, F. Pavone, S. Marinelli |
IFC |
Promoting patient safety by a novel combination of imaging technologies for biodegradable magnesium implants (MgSafe)
| Diagnostic tools (e.g. genetic, molecular diagnostic), Materials engineering, In vitro cell and tissue imaging, In vivo bio- and medical- imaging, Medical engineering and Technology | L. Menichetti, D. Panetta |
IBBC |
Protective effect of a multi-strain probiotic (BP-002) in a mouse model of neuroinflammation induced by LPS: role of gut-brain axis
| Gut Brain Axis, Neuroinfammation, Adult neurogenesis, LPS, Probiotics | S. Farioli-Vecchioli, C. Petrella, F. De Santa, G. Strimpakos |
IBBC |
Protein mono-ADP-ribosylation in the control of cell physio-pathology
| mono-ADP-ribosylation; membrane transport; cancer | G. Grimaldi |
IBFM |
Proteomics and metabolomics studies of adrenal cancer and benign adrenal neoplasia: new in-sights in the pathogenesis of adrenal masses
| Proteomics, Metabolomics, Adrenal cancer | M. Ripamonti |
IFT |
Protocolli di immunizzazione genetica mediante elettroporazione e identificazione di biomarcatori in patologie tumorali
| gene electrotransfer; pre-clinical protocols; biomarkers | E. Signori |
IBBC |
Pyrvinium Pamoate drug Induces Death of Triple-Negative Breast Cancer Stem– Like Cells and Reduces Metastases through its effects on Lipid Anabolism
| breast cancer, cancer progression, metastasis, stem cell biology, molecular markers of metastasis and progression, cancer metabolism, lipid anabolism, mitochondria, OxPHOS, computational methods, gene expression profiling, molecular modeling | L. Cardone |
IN |
Quantification of vascular microangioarchitectures in physiopathological neural contexts
| anti-angiogenesis, vascular retina, AMD | M. Righi |
IGB |
Quantitative analysis of immunological memory
| Immunological memory, antibody, β-amyloid | A. Prisco |
IBFM |
Radiomics for Preclinical and Clinical Applications
| Radiomics, Biomedical image analysis,Preclinical and clinical studies, Machine learning, Deep learning | A. Stefano |
IBFM |
Radiotherapy and biologic effects of radiations
| Radiotherapy; Adrotherapy, Radiobiology; Radiosensitization; Space radiobiology | IBFM-CNR, Cefalù team |
IN |
Reciprocal interactions between astrocytes and neurons in brain physiology and pathology
| Astrocytes, calcium, GCaMP6f, optogenetics, chemogenetics, synaptic transmission, synaptic plasticity, memory, Dravet syndrome, Alzheimer’s disease, BDNF, entorhinal/perirhinal/somatosensory/visual cortex, hippocampus, ventral tegmental area | G. Carmignoto |
IBBC |
Regulation of Golgi unlinking during G2/M transition
| Golgi complex, cell cycle, PKD, MAPK kinase | I. Ayala |
IBBC |
REGULATION OF THE BIOSYNTHETIC MEMBRANE TRANSPORT APPARATUS
| Membrane transport, control systems, autoregulation | A. Luini |
IFT |
Regulation of the stress response in inflammation, cancer and viral infection
| HSF, anticancer drugs, inflammation, proteotoxic stress, NF-kappaB, viral infection | A. Rossi, M.G. Santoro |
IFT |
Regulatory Science and translational drug development
| Regulatory Science, Technology Transfer, drug discovery | P. Pierimarchi |
IFT |
Research Team: Monica Rinaldi, Sandra Iurescia, Daniela Fioretti
| --- | M. Rinaldi, S. Iurescia, D. Fioretti |
IFT |
Resolution of inflammation: pro-resolving lipid mediators as novel diagnostic and therapeutic strategies
| Chronic inflammation, resolution, lipids, innate and adaptive immunity, biomarkers, resolution pharmacology | V. Chiurchiù |
IBPM |
Response to glucocorticoids in cultured hippocampal neurons from mdx mice and in human and mouse cell lines
| glucocorticoids; Duchenne Muscular Dystrophy; stress | P. Fragapane |
IBBC |
Re-Using old drugs against cancer: Computational drug repurposing identified decitabine for targeted therapy in KRAS-dependent Pancreatic Ductal Adenocarcinoma by exploiting pyrimidine biosynthesis addiction
| pancreatic cancer, functional genomics, cell death and senescence, drug targets, oncoprotein, small molecule agents, oncogenes, cancer metabolism, pyrimidine biosynthesis, drug discovery technologies, in silico evaluation of drug repurposing | L. Cardone |
IEOS |
Risk for Type 2 Diabetes and comorbidities – a molecular perspective
| Cancer; Diabetes; Epigenetics | V. D'Esposito |
IN |
Role of biological markers for the risk stratification of cerebral bleeding and ischemic stroke in patients with atrial fibrillation on oral anticoagulants for primary or secondary prevention of ischemic stroke: the Strat-AF2 Study
| Atrial fibrillation, circulating biomarkers, ischemic stroke | A. Di Carlo |
IN |
Role of Calcium activity in cell invasion and migration by Intravital Two-photon Imaging of Glioblastoma Mouse Models
| changes in network excitability, GBM models, peritumoral/tumoral area | S. Landi |
IBBC |
Role of cell cycle regulators in the control of skeletal muscle function in physiological and pathological conditions
| Muscle metabolism, Cell cycle regulators, muscular dystrophy | M. Caruso |
IN |
Role of interhemispheric connections in health and disease
| corpus callosum, neuronal plasticity, epilepsy | L. Restani |
IN |
Role of microglia in the control of synaptic homeostasis
| synapse, dendritic spines, synaptic pruning, microglia, innate immune system, TREM2 | M. Matteoli |
IFT |
Role of miR-200c in oxidative stress-induced pathologies
| microRNA, oxidative stress, endothelial dysfunction, oxidative stress-associated diseases | A. Magenta |
IBPM |
Role of noncoding RNAs in neuronal homeostasis and disease
| noncoding RNAs; stress; Autism Spectrum Disorder | C. Mannironi |
IN |
Role of Pentraxin3-thrombospondin1 complex in neurodevelopmental diseases
| synapse dysfunction, synaptogenesis, synaptic plasticity, AMPA receptors, glial cells, innate immune system | E. Menna |
IN |
ROLE OF RARE MISSENSE VARIANTS OF THE HUMAN β4 (BETA) SUBUNIT IN THE EXPRESSION AND SURFACE EXPOSURE OF α3β4 NICOTINIC RECEPTORS
| Neuronal nicotinic receptors; intracellular trafficking; missense variants | S. F. Colombo |
IN |
Role of Tau in chromatin remodeling and gene expression
| Tau, Chromatin, gene expression | C. Di Primio |
IFT |
Scientific dissemination – "Comunicare La Ricerca"
| Scientific dissemination | S. Iurescia, D. Fioretti |
IGM |
Screening platform for anticancer and antiviral drugs
| antiviral/anticancer drug development, small molecule inhibitors, target validiation | G. Maga, E. Crespan |
IBBC |
SENSORY DECAYS and AGING (SENSAGING)
| Sensory system, aging, genomics, metabolomics, functional analysis, sensory decay | M. Raspa, A. Tettey Matey |
ITB |
Single Cell transcriptomic analysis of tumor patient-derived organoids
| Single Cells Analysis, Breast Cancer, Organoids | P. Pelucchi, E. Mosca |
IBFM |
Sleep and Neurodegeneration: novel biomarkers for new challenges
| Sleep Disorders, Alzheimer’s Disease; Parkinson’s Disease | M. Salsone |
IN |
SOCIAL AND MOTOR ASPECTS OF AUTISM SPECTRUM DISORDERS
| autism spectrum disorders, motor development, social cognition, mirror mechanism | M. Fabbri Destro |
IN |
Social implications and neural correlates in planning and execution of licking behavior
| motor planning, licking, social facilitation | C. Alia |
IRGB |
Soluble BAFF Inhibition by small molecules: Virtual Screening drug discovery driven by genetics
| Virtual Screening, genetics, assay | S. Olla, F. Cucca |
IFT |
SOSTANZE NATURALI: IMMUNOFARMACOLOGIA ED ONCOLOGIA INTEGRATA
| resveratrolo, polidatina, dual target drug, neoantigeni, caspasi inibitori, IL-1β, infiammazione | M.P. Fuggetta |
IBB |
Spectroscopic analysis and biological evaluation of novel synthetic molecules and natural drugs for biomedical applications
| G-quadruplex, anticancer strategies, spectroscopic methods | G.N. Roviello |
IBBC |
sPLA2-IIA regulates osteoclast differentiation and function
| Phospholipase A2, osteoclastogenesis, p-38 SAPK | S. Mariggiò |
IBPM |
Spontaneous RNA polymerization and ricombination: implications for RNA metabolism and the "RNA World" hypothesis
| origin of life; prebiotic chemistry; RNA world | G. Costanzo, A. Cirigliano, |
IBBC |
SSR-SPECT/CT device: a new method for the small animal imaging study
| Small animal SPECT, Monte Carlo simulation, Super Spatial Resolution, Neuroimaging | R. Massari |
IRGB |
Statistical methods for powerful identification of causal mechanisms underlying complex traits and diseases
| Causal inference, Microbiome, cholesterol | S. Sanna |
IBPM |
Stereocontrolled total synthesis of iminosugars and their lipophilic derivatives with potential therapeutic activity
| stereodivergent synthesis; iminosugars; drug delivery. | G. Righi, A. Ricelli |
IBIOM |
Strategy for p53 tumour suppressor reactivation in chemo-resistant tumours
| p53, TRIM8, chemoresistance | A. Tullo |
IBB |
Structural characterization of the porphyrins/proteasome interaction
| Porphyrins, Proteasome inhibitors, NMR spectroscopy | D. Diana |
IBB |
Structure-based approaches for therapeutic and diagnostic applications
| protein structure; antibiotic; cancer | R. Berisio |
IRGB |
STUDIO FUNZIONALE DI VARIANTI DEL LOCUS CD40 ASSOCIATI ALLA PREDISPOSIZIONE A MALATTIE AUTOIMMUNI
| Sclerosi Multipla, CD40, CD27 | A. Meloni, V. Faà, I. Asunis, F. Cucca |
IBBC |
STUDY OF NEW PHARMACOLOGICAL TARGETS FOR AUTISM SPECTRUM DISORDER BY USING INNOVATIVE NEUROIMAGING TECHNIQUES APPLIED TO THE CONSCIOUS LABORATORY ANIMAL
| Autism spectrum, social behaviour, Small Animal SPECT, lightweight scintigraphyc devices | R. Massari |
IBPM |
Studying the role of long noncoding RNAs in neuronal physiology and their impact in brain cancer and neurodegeneration
| noncoding RNAs; brain tumours; neurodegeneration | E. Caffarelli, P. Laneve |
IN |
Synaptic dysfunctions and potential therapies for Phelan McDermid Syndrome
| Shank3, SULT4A1, synapse | C. Verpelli |
IFT |
TACKLING INTRATUMOR HETEROGENEITY: SEARCHING FOR NEW CURE
| ITH (IntraTumor Heterogeneity); Genomics; Metabolism | V.M. Fazio |
IBBC |
Targeted vaccination using novel nano-carriers
| filamentous bacteriophage, vaccine, dendritic cells, invariant natural killer T cells, alphagalactosylceramide, anti tumor immunity. | P. De Berardinis, R. Sartorius, L. D’Apice |
IN |
Targeting Ca2+ and mitochondrial dysfunctions to fight neurological deficits
| excitotoxicity, calcium and mitochondrial dynamics, cell death | B. D'Orsi |
IBPM |
Targeting DNA damage and autophagy as potential therapeutic approach for cancer and neurodegenerative diseases
| 3D model system; cancer; Ataxia Telangiectasia | V. Stagni |
IFT |
Targeting epithelial and hematologic cancer by Fcγ-CR engineered T cells or longterm NK cells
| Fcγ-CR T cells, NK cells, cancer immunotherapy | G. Sconocchia, S. Caratelli, G. Lanzilli |
IN |
Targeting inflammation to rescue cone photoreceptors inRetinitis Pigmentosa (RP)
| retina, inflammation, blindness | E. Strettoi |
IBBC |
Targeting metabolic disturbances of central cholinergic circuits to recover cognition in AD and T2D
| NGF, BFCN, brain insulin resistance, oxysterols, Alzheimer’s Disease, T2D | V. Triaca |
IBIOM |
TARGETING MITOCHONDRIA IN NEURODEVELOPMENTAL DISEASES
| Mitochondrial dysfunction; neurodevelopmental diseases; bioactive natural compounds | R. A. Vacca |
IRGB |
Targeting mitochondria to treat rare and common neurodegenerative disorders
| Mitochondria, MicroRNA, Neurodegenerative Disorders | A. Indrieri |
IGB |
Targeting oncogenic lncRNA and tumor cell metabolism to overcome drug resistance in BRAF-mutated thyroid carcinomas
| Molecular Oncology; Drug Resistance; Omic Technologies | V. Costa |
IBB |
Targeting Sam-Sam interactions mediated by EphA2 receptor: design and evaluation of peptide inhibitors
| ONCOLOGY; STRUCTURAL BIOLOGY; NMR | M. Leone |
IGB |
Targeting the cancer (stem) cells – tumor microenvironment crosstalk to improve pancreatic cancer prognosis
| Pancreatic Cancer Stem Cells; TGFbeta; Tumor microenvironment | E. Lonardo |
IN |
Targeting the oxytocin system: novel therapeutic agents for neurodevelopmental diseases and neuropsychiatric disorders
| oxytocin analogues, neuropsychiatric disease, neurodevelopmental disorders | M. Busnelli, B. Chini |
IBPM |
Telomeres structure and function: from the safeguard of genetic stability to cell immortality
| telomeres; G-quadruplexes; cancer | E. Salvati |
IBFM |
Temporal Lobe Epilepsy (TLE): Circulating microRNAs as biomarkers for the differential diagnosis and prediction of therapeutic response in TLE
| TLE circulating biomarkers, Diagnosis, Drug-resistance prediction | C. Cava, I. Manna, A. Gambardella, G. Bertoli |
IBB |
The crystal structure of KCTD1 prompts for a new structural/functional re-classification of the KCTD protein family
| domain swapping, protein function, human disease | L. Vitagliano |
IFT |
The effects of NGF, proNGF forms and their receptor inhibition on immune response in chronic inflammatory diseases
| Inflammation, cytokines, NGF receptors | L. Bracci Laudiero |
IBFM |
The elusive ink between FDG uptake and glucose consumption unravels an unexpected metabolic role of endoplasmic reticulum
| Endoplasmic reticulum; PET, cancer; Glucose metabolism neurodegenerative disorders, Oxidative stress; SOD1G93A mouse model; Skeletal muscle; [18F]- Fluorodeoxyglucose | C. Marini |
IBBC |
The glycerophosphoinositols: definition of the cellular receptor and its involvement in tumor invasion
| Glycerophosphoinositols, Src homology region 2 domain-containing phosphatase-1 (Shp1), actin cytoskeleton | A. Varone |
IBPM |
The HIPK2 kinase/spastin axis in cancer and neurodegeneration
| pancreatic cancer; organoids; Hereditary Spastic Paraplegia | C. Rinaldo |
IRGB |
The impact of ageing, sex, environment and genetics in the immune system: an integrated approach to dissect immunosenescence
| immune system, ageing, genetics | M. Steri, V. Orrù, E. Fiorillo, F. Cucca |
IFT |
The impact of the ubiquitin-system in tumorigenesis
| Ubiquitin-dependent degradation, protein stability, E3 ubiquitin ligases, WWP1 | A. Peschiaroli |
ESFRI-INFRAFRONTIER |
The Infrafrontier Landmark Research Infrastructure and the European Mouse Mutant Archive (EMMA) - Mouse Disease Models for the Scientific Community
| bio-repository, phenogenomics, preclinical research, translational and personalised medicine | emma@infrafrontier.eu, mouse.resources@emma.cnr.it |
IN |
The interaction of the mitochondrial inhibitor protein IF1 with ATP synthase modulates the permeability transition pore in a human cancer cell model
| IF1, Permeability Transition Pore, cancer, ATP synthase | V. Giorgio, V. Petronilli |
ESFRI-INFRAFRONTIER |
The International Centre for Genetic Engineering and Biotechnology (ICGEB) - European Mouse Mutant Archive (EMMA). Workshops and courses on mouse models of disease and genome editing.
| mouse models, genome editing, embryo manipulation, human diseases | S. Zacchigna (ICGEB), M. Raspa (IBBC-EMMA), A. Muro (ICGEB), E. Lippolis (ICGEB) |
IRGB |
The interplay between cellular aging and immune response in human colorectal liver metastasis: senescence as a new prognostic marker?
| Cellular Senescence, Metastasis, Immune cells | F. Faggioli |
IBBC |
The intriguing life of SMN at the plasma membrane: not only a matter of Spinal Muscular Atrophy
| SMN, SMA, RNA metabolism, plasma membrane, ribosome | M.G. Di Certo |
IN |
THE MIRROR MECHANISM
| action execution, action observation, social cognition, mirror mechanism | P. Avanzini |
IGM |
The RNA helicase DDX3X in cancer and viral infections
| RNA helicase DDX3X, broad spectrum antivirals, alternative ribonucleotide excision repair | G. Maga |
ITB |
The Role of TMEM230 in angiogenesis, tissue remodeling and autoimmunity
| angiogenesis, tissue remodeling, autoimmunity, 3D cellular models | C. Cocola |
IFT |
The study of metabolic alterations in Amyotrophic Lateral Sclerosis: a new therapeutic approach
| Amyotrophic Lateral Sclerosis, Hypermetabolism, Bioenergetics | A. Ferri, C. Valle |
IFT |
The Wnt/β-catenin pathway as therapeutic target for oncological and neurodegenerative diseases
| Wnt/β-catenin pathway, Parkinson’s disease, cancer therapy and diagnosis | A. Serafino |
IBB |
Theranostic nanoparticles based approach targeting a set of microRNAs in drug resistant breast cancers
| Preclinical Molecular Imaging, Breast Cancer, Theranostic nanoparticles | A. Zannetti |
IFT |
Therapeutic strategies to target glioblastoma multiforme: the cancer stem cells model
| Glioblastoma cancer stem cells, anti-cancer drugs, immunotherapy | C. Cenciarelli |
IGB |
Toward the reactivation of the dormant allele of MECP2 as a therapy for Rett syndrome: a dual-reporter system to trace the allele specific expression of Mecp2 and study its function in neurogenesis
| Mecp2-pathies, X chromosome reactivation, epigenetics | M. Vacca, L. Casalino |
IBBC |
Translational medicine in HEAD/NECK CANCER: Laryngeal carcinoma
| Cancer; invasiveness; growth factors; neuropeptides; vgf; stem cells; human tumor bioptic tissues | IBBC Unit at Department of Sense Organs, Sapienza University of Rome |
IN |
Translational Neuroscience and Brain Training
| brain plasticity, dementia, environmental enrichment | A. Sale |
IGM |
Translesion synthesis and DNA damage tolerance
| Damage tolerance, polymerase eta, DNA Replication | S. Sabbioneda |
IGM |
TSPYL2, a sex specific player in the DNA damage response of cancer cells
| DNA damage, apoptosis, sexual dimorphism | L. Zannini |
IBBC |
TTF-2/FoxE1 as co-repressor of thyroid hormone receptors activity
| thyroid, estrogen, FoxE1/TTF-2, thyroid-specific gene expression | D. Civitareale |
IN |
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3
| Neurofibromin, SIRT3, TRAP1 | I. Masgras |
IN |
Understanding changes that occur in peritumoral tissue during glioma progression and finding novel approaches to develop effective therapeutic strategies to counteract glioma growth
| glioma; brain tumor; epilepsy | E. Vannini |
IEOS |
Unraveling the role of dicarbonyl stress in the progression of type 2 diabetes and vascular dysfunction
| Diabetes Mellitus; Endothelial dysfunction; Glucotoxicity | C. Miele, C. Nigro |
IBBC |
Unravelling the signaling and molecular pathways downstream Golgi fragmentation
| Golgi complex, cell cycle checkpoint, signaling, Antibody Microarray | D. Spano |
IBIOM |
YEAST AS A MODEL FOR FUNDAMENTAL AND APPLIED CELL BIOLOGY
| mitochondria, signaling, humanized yeast | S. Giannattasio |
IBBC |
ZIMMERMANN-LABAND SYNDROME: FUNCTIONAL STUDIES TO CHARACTERIZE CAUSATIVE MUTATIONS IN KCNH1 GENE
| Neurodevelopmental disorders, primary cilium, KCNH1 | C. Parisi |